GB2430622B - Inhaled combination therapy - Google Patents

Inhaled combination therapy

Info

Publication number
GB2430622B
GB2430622B GB0620830A GB0620830A GB2430622B GB 2430622 B GB2430622 B GB 2430622B GB 0620830 A GB0620830 A GB 0620830A GB 0620830 A GB0620830 A GB 0620830A GB 2430622 B GB2430622 B GB 2430622B
Authority
GB
United Kingdom
Prior art keywords
combination therapy
inhaled combination
inhaled
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0620830A
Other versions
GB0620830D0 (en
GB2430622A (en
Inventor
Justian Craig Fox
Mary Frances Fitzgerald
Harry Finch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0502949A external-priority patent/GB0502949D0/en
Priority claimed from GB0526124A external-priority patent/GB0526124D0/en
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Priority to GB0716700A priority Critical patent/GB2442828A/en
Priority claimed from PCT/GB2006/000482 external-priority patent/WO2006085102A1/en
Publication of GB0620830D0 publication Critical patent/GB0620830D0/en
Publication of GB2430622A publication Critical patent/GB2430622A/en
Application granted granted Critical
Publication of GB2430622B publication Critical patent/GB2430622B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0620830A 2005-02-11 2006-02-13 Inhaled combination therapy Expired - Fee Related GB2430622B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0716700A GB2442828A (en) 2005-02-11 2006-02-13 Combination of a methylxanthine compound and a steroid to treat chronic respiratory disease

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0502949A GB0502949D0 (en) 2005-02-11 2005-02-11 Combination therapy
GB0526124A GB0526124D0 (en) 2005-12-22 2005-12-22 Inhaled combination therapy
PCT/GB2006/000482 WO2006085102A1 (en) 2005-02-11 2006-02-13 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases

Publications (3)

Publication Number Publication Date
GB0620830D0 GB0620830D0 (en) 2006-12-13
GB2430622A GB2430622A (en) 2007-04-04
GB2430622B true GB2430622B (en) 2008-03-05

Family

ID=37547091

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0620830A Expired - Fee Related GB2430622B (en) 2005-02-11 2006-02-13 Inhaled combination therapy

Country Status (1)

Country Link
GB (1) GB2430622B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0421587A2 (en) * 1989-08-10 1991-04-10 Beecham Group p.l.c. Xanthine derivatives used in asthma
WO2006013359A1 (en) * 2004-08-05 2006-02-09 Argenta Discovery Limited Medicaments for treating chronic respiratory disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0421587A2 (en) * 1989-08-10 1991-04-10 Beecham Group p.l.c. Xanthine derivatives used in asthma
WO2006013359A1 (en) * 2004-08-05 2006-02-09 Argenta Discovery Limited Medicaments for treating chronic respiratory disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Evans D J et al "A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma" The New England Journal of Medicine, vol 337 no.20, 1997, pages 1412-1418 *
Morali T et al "Efficacy of Inhaled Budesonide and oral theophylline in asthmatic subjects" vol 38(8) page 673-679, 2001 *
Rivington R N et al "Efficacy of Uniphyl, Salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids" American Journal of Respiratory and Critical Care vol. 151 1995 pages 325-332 *

Also Published As

Publication number Publication date
GB0620830D0 (en) 2006-12-13
GB2430622A (en) 2007-04-04

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
GB0520794D0 (en) Inhaler
GB0519151D0 (en) Inhaler
EP1859828A4 (en) Inhaler
GB0504206D0 (en) Combination therapy
GB0505538D0 (en) Inhalation devices
GB0505543D0 (en) Inhalation devices
GB0509052D0 (en) Combination therapy
GB0505545D0 (en) Inhalation devices
EP1862192A4 (en) Inhalator
GB0417481D0 (en) Combination therapy
GB0428180D0 (en) Combination therapy
ZA200709627B (en) Combination therapy
GB0507003D0 (en) Therapeutic
GB0505540D0 (en) Inhalation devices
GB0424339D0 (en) Combination therapy
GB0518720D0 (en) Therapeutic combination
GB0501655D0 (en) Therapeutic use
GB0716700D0 (en) Inhaled combination theraphy
GB0505542D0 (en) Inhalation devices
GB0510091D0 (en) Inhaler
GB2430622B (en) Inhaled combination therapy
GB0526124D0 (en) Inhaled combination therapy
GB0421438D0 (en) Combination therapy
GB0421436D0 (en) Combination therapy

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20100213

S73 Revocation on comptroller's initiative (section 73/patents act 1977)

Free format text: PATENT REVOKED; PATENT REVOKED UNDER SECTION 73(2) ON 1 NOVEMBER 2010